Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study
P B Jeppesen, M Pertkiewicz, A Forbes, L Pironi, S M Gabe, F Joly, B Messing, S Loth, N N Youssef, H Heinze, P Berghöfer
81Citationer
(Scopus)
Fingeraftryk
Dyk ned i forskningsemnerne om 'Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study'. Sammen danner de et unikt fingeraftryk.